Purchases and Sales Made in Q1 2024 in Day One Biopharmaceuticals, Inc. (DAWN)
This table provides information about the institutional ownership of Day One Biopharmaceuticals, Inc. (DAWN) during Q1 2024. The information is specifically focused on institutions that hold shares of Day One Biopharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2024
Q1 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-17K- 0.73% |
$231K - $297K
|
2.3M
$22.3M
|
|
May 15, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-17.5K- 82.54% |
$237K - $306K
|
3.71K
$35.9K
|
|
May 14, 2024
Q1 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-18.6K- 3.23% |
$252K - $325K
|
558K
$5.41M
|
|
May 15, 2024
Q1 2024
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-20K- 2.91% |
$271K - $349K
|
666K
$6.46M
|
|
May 15, 2024
Q1 2024
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-20.4K- 3.97% |
$276K - $356K
|
493K
$4.78M
|
|
May 01, 2024
Q1 2024
|
Mirae Asset Global Investments Co., Ltd.
|
SELL
|
- |
-22.3K- 50.45% |
$302K - $389K
|
21.9K
$212K
|
|
May 14, 2024
Q1 2024
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-24.1K- 44.33% |
$327K - $421K
|
30.3K
$294K
|
|
May 15, 2024
Q1 2024
|
Superstring Capital Management LP
New York, NY |
SELL
|
- |
-29.9K- 7.89% |
$406K - $523K
|
350K
$3.39M
|
|
May 07, 2024
Q1 2024
|
Times Square Capital Management, LLC
|
SELL
|
- |
-30.9K- 1.86% |
$419K - $540K
|
1.64M
$15.9M
|
|
May 15, 2024
Q1 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-32.3K- 20.2% |
$438K - $564K
|
128K
$1.24M
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-33.6K- 32.05% |
$455K - $586K
|
71.2K
$691K
|
|
May 13, 2024
Q1 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-43.1K- 18.25% |
$585K - $753K
|
193K
$1.87M
|
|
May 08, 2024
Q1 2024
|
Td Asset Management Inc
|
SELL
|
- |
-44.4K- 80.44% |
$602K - $775K
|
10.8K
$105K
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-94.6K- 1.85% |
$1.28M - $1.65M
|
5.03M
$48.8M
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-102K- 30.47% |
$1.38M - $1.78M
|
233K
$2.26M
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-102K- 30.47% |
$1.38M - $1.78M
|
233K
$2.26M
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-118K- 63.7% |
$1.61M - $2.07M
|
67.5K
$654K
|
|
May 14, 2024
Q1 2024
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-127K- 56.54% |
$1.72M - $2.22M
|
97.6K
$947K
|
|
May 14, 2024
Q1 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-196K- 7.64% |
$2.66M - $3.43M
|
2.38M
$23M
|
|
May 15, 2024
Q1 2024
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-200K- 14.44% |
$2.71M - $3.49M
|
1.19M
$11.5M
|
|
May 03, 2024
Q1 2024
|
First Turn Management, LLC
Del Mar, CA |
SELL
|
- |
-383K- 22.5% |
$5.19M - $6.68M
|
1.32M
$12.8M
|
|
May 13, 2024
Q1 2024
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-430K- 10.15% |
$5.83M - $7.51M
|
3.81M
$36.9M
|
|
May 15, 2024
Q1 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-485K- 14.36% |
$6.58M - $8.47M
|
2.89M
$28.1M
|
|
May 14, 2024
Q1 2024
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-948K- 72.75% |
$12.9M - $16.6M
|
355K
$3.45M
|
|
May 03, 2024
Q1 2024
|
Atlas Venture Life Science Advisors, LLC
|
SELL
|
- |
-1.18M- 15.48% |
$16M - $20.6M
|
6.43M
$62.4M
|
|
May 15, 2024
Q1 2024
|
Braidwell LP
Stamford, CT |
SELL
|
- |
-2.04M- 48.44% |
$27.7M - $35.7M
|
2.17M
$21.1M
|